246 related articles for article (PubMed ID: 9619780)
21. Transcellular and lipophilic complex-enhanced intestinal absorption of human growth hormone.
Wu SJ; Robinson JR
Pharm Res; 1999 Aug; 16(8):1266-72. PubMed ID: 10468030
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.
Augustijns PF; Bradshaw TP; Gan LS; Hendren RW; Thakker DR
Biochem Biophys Res Commun; 1993 Dec; 197(2):360-5. PubMed ID: 7903526
[TBL] [Abstract][Full Text] [Related]
23. Nucleobase- and p-glycoprotein-mediated transport of AG337 in a Caco-2 cell culture model.
Hu M; Chen J
Mol Pharm; 2004; 1(3):194-200. PubMed ID: 15981922
[TBL] [Abstract][Full Text] [Related]
24. A biophysical model of passive and polarized active transport processes in Caco-2 cells: approaches to uncoupling apical and basolateral membrane events in the intact cell.
Ho NF; Burton PS; Conradi RA; Barsuhn CL
J Pharm Sci; 1995 Jan; 84(1):21-7. PubMed ID: 7714738
[TBL] [Abstract][Full Text] [Related]
25. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
Wu X; Whitfield LR; Stewart BH
Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
[TBL] [Abstract][Full Text] [Related]
26. Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.
Batrakova EV; Li S; Miller DW; Kabanov AV
Pharm Res; 1999 Sep; 16(9):1366-72. PubMed ID: 10496651
[TBL] [Abstract][Full Text] [Related]
27. Functional characterization of peptide transporters in MDCKII-MDR1 cell line as a model for oral absorption studies.
Agarwal S; Jain R; Pal D; Mitra AK
Int J Pharm; 2007 Mar; 332(1-2):147-52. PubMed ID: 17097248
[TBL] [Abstract][Full Text] [Related]
28. [Studies on predict of absorption of corynanthine, yohimbine, ajmalicine and ajmaline across human intestinal epithelial by using human Caco-2 cells monolayers].
Ma L; Yang XW
Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2373-7. PubMed ID: 19157132
[TBL] [Abstract][Full Text] [Related]
29. The influence of donor and reservoir additives on Caco-2 permeability and secretory transport of HIV protease inhibitors and other lipophilic compounds.
Aungst BJ; Nguyen NH; Bulgarelli JP; Oates-Lenz K
Pharm Res; 2000 Oct; 17(10):1175-80. PubMed ID: 11145221
[TBL] [Abstract][Full Text] [Related]
30. Enhanced permeability of the antimicrobial agent 2,5-bis(4-amidinophenyl)furan across Caco-2 cell monolayers via its methylamidoidme prodrug.
Zhou L; Lee K; Thakker DR; Boykin DW; Tidwell RR; Hall JE
Pharm Res; 2002 Nov; 19(11):1689-95. PubMed ID: 12458675
[TBL] [Abstract][Full Text] [Related]
31. Determination of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence detection: application to transport studies.
Zhou S; Feng X; Kestell P; Baguley BC; Paxton JW
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):87-97. PubMed ID: 15282097
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of an accelerated Caco-2 cell permeability model.
Liang E; Chessic K; Yazdanian M
J Pharm Sci; 2000 Mar; 89(3):336-45. PubMed ID: 10707014
[TBL] [Abstract][Full Text] [Related]
33. Transport of peptidomimetic thrombin inhibitors with a 3-amidino-phenylalanine structure: permeability and efflux mechanism in monolayers of a human intestinal cell line (Caco-2).
Kamm W; Hauptmann J; Behrens I; Stürzebecher J; Dullweber F; Gohlke H; Stubbs M; Klebe G; Kissel T
Pharm Res; 2001 Aug; 18(8):1110-8. PubMed ID: 11587481
[TBL] [Abstract][Full Text] [Related]
34. Transport characteristics of peptides and peptidomimetics: II. Hydroxyethylamine bioisostere-containing peptidomimetics as substrates for the oligopeptide transporter and P-glycoprotein in the intestinal mucosa.
Gao J; Winslow SL; Vander Velde D; Aubé J; Borchardt RT
J Pept Res; 2001 May; 57(5):361-73. PubMed ID: 11350596
[TBL] [Abstract][Full Text] [Related]
35. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.
Tang F; Ouyang H; Yang JZ; Borchardt RT
J Pharm Sci; 2004 May; 93(5):1185-94. PubMed ID: 15067695
[TBL] [Abstract][Full Text] [Related]
36. Transport and metabolism of delta sleep-inducing peptide in cultured human intestinal epithelial cell monolayers.
Augustijns PF; Borchardt RT
Drug Metab Dispos; 1995 Dec; 23(12):1372-8. PubMed ID: 8689946
[TBL] [Abstract][Full Text] [Related]
37. Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data.
Kamm W; Raddatz P; Gante J; Kissel T
Pharm Res; 1999 Oct; 16(10):1527-33. PubMed ID: 10554093
[TBL] [Abstract][Full Text] [Related]
38. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
39. Transport of IRW, an ovotransferrin-derived antihypertensive peptide, in human intestinal epithelial Caco-2 cells.
Bejjani S; Wu J
J Agric Food Chem; 2013 Feb; 61(7):1487-92. PubMed ID: 23298184
[TBL] [Abstract][Full Text] [Related]
40. Effects of chlorophyllin on transport of dibenzo(a, l)pyrene, 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine, and aflatoxin B(1) across Caco-2 cell monolayers.
Mata JE; Yu Z; Gray JE; Williams DE; Rodriguez-Proteau R
Toxicology; 2004 Mar; 196(1-2):117-25. PubMed ID: 15036761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
